Frequently Asked Questions
1. What is immunotherapy for lung cancer?
Immunotherapy is a treatment that helps the body’s immune system detect and attack lung cancer cells. It may include immune checkpoint inhibitors, CAR-T therapy, cancer vaccines, or monoclonal antibodies, tailored to the patient’s condition.
2. Who is eligible for immunotherapy?
Eligibility depends on cancer stage, tumor markers like PD-L1, overall health, and prior treatments. Our specialists assess each patient to determine the most suitable therapy plan.
3. How is immunotherapy administered?
Immunotherapy may be delivered via intravenous infusion, injection, or oral medications depending on the therapy type. Treatments are closely monitored by our oncology team for safety and effectiveness.
4. What side effects should I expect?
Side effects can include fatigue, flu-like symptoms, mild skin reactions, or inflammation in organs. Our specialists monitor patients closely and provide timely management to ensure safety and comfort.
5. How long does the treatment take?
The duration varies based on therapy type, cancer stage, and patient response. Some patients undergo treatment for several weeks to months, with regular follow-ups to monitor progress.
6. Can immunotherapy be combined with other treatments?
Yes. Immunotherapy can be used alongside chemotherapy, radiation, or targeted therapies to improve outcomes, depending on the patient’s condition and treatment plan.
7. How do I schedule a consultation?
You can book a consultation with our lung cancer specialists to discuss treatment options and develop a personalized care plan suited to your needs.
8. Is immunotherapy covered by insurance?
Coverage depends on your insurance provider and plan. Our patient care team can guide you through insurance queries and financing options for immunotherapy in India.
